AQR Capital Management’s Niagen Bioscience NAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.55M	Buy	1,031,335 +425,381	+70%	+$2.3M	﹤0.01%	1809
2025 Q4	$3.85M	Buy	605,954 +18,957	+3%	+$132K	﹤0.01%	1738
2025 Q3	$5.48M	Buy	586,997 +95,386	+19%	+$963K	﹤0.01%	1403
2025 Q2	$7.08M	Buy	491,611 +139,475	+40%	+$1.38M	0.01%	1106
2025 Q1	$2.43M	Buy	352,136 +329,425	+1,451%	+$2.07M	﹤0.01%	1504
2024 Q4	$120K	Buy	22,711 +3,075	+16%	+$16.8K	﹤0.01%	2746
2024 Q3	$71.7K	Buy	+19,636	New	+$61.8K	﹤0.01%	2684
2022 Q4	–	Sell	-76,571	Closed	-$94K	–	2297
2022 Q3	$94K	Sell	76,571 -156,232	-67%	-$251K	﹤0.01%	2111
2022 Q2	$389K	Sell	232,803 -180,986	-44%	-$354K	﹤0.01%	1766
2022 Q1	$1.02M	Buy	413,789 +181,358	+78%	+$496K	﹤0.01%	1523
2021 Q4	$869K	Buy	232,431 +60,590	+35%	+$327K	﹤0.01%	1617
2021 Q3	$1.08M	Buy	171,841 +55,854	+48%	+$460K	﹤0.01%	1496
2021 Q2	$1.14M	Buy	115,987 +38,650	+50%	+$337K	﹤0.01%	1524
2021 Q1	$722K	Sell	77,337 -81,559	-51%	-$646K	﹤0.01%	1691
2020 Q4	$763K	Buy	158,896 +17,695	+13%	+$86.3K	﹤0.01%	1616
2020 Q3	$566K	Buy	+141,201	New	+$681K	﹤0.01%	1667
2019 Q4	–	Sell	-23,024	Closed	-$91K	–	2192
2019 Q3	$91K	Buy	+23,024	New	+$98.2K	﹤0.01%	2085